Literature DB >> 16679640

Verbal and visual memory in patients with early Parkinson's disease: effect of levodopa.

Sumit Singh1, Madhuri Behari.   

Abstract

BACKGROUND: The effect of initiation of levodopa therapy on the memory functions in patients with Parkinson's disease remains poorly understood. AIMS: To evaluate the effect of initiation of levodopa therapy on memory, in patients with early Parkinson's disease. SETTINGS AND
DESIGN: Prospective case control study.
MATERIALS AND METHODS: Seventeen patients with early Parkinson's disease were evaluated for verbal memory using Rey's auditory verbal learning test, and visual memory using the Benton's visual retention test and Form sequence learning test. UPDRS scores, Hoehn and Yahr's Staging and Schwab and England scores of Activities of daily living. Hamilton's depression rating scale and MMSE were also evaluated. Six controls were also evaluated according to similar study protocol. Levodopa was then prescribed to the cases. Same tests were repeated on all the subjects after 12 weeks.
RESULTS: The mean age of the patients was 59.8 (+ 12.9 yrs); mean disease duration of 3.26 (+ 2.06 yrs). The mean UPDRS scores of patients were 36.52 (+ 15.84). Controls were of a similar age and sex distribution. A statistically significant improvement in the scores on the UPDRS, Hamilton's depression scale, Schwab and England scale, and a statistically significant deterioration in the scores of visual memory was observed in patients with PD after starting levodopa, as compared to their baseline scores. There was no correlation between degree of deterioration and the dose of levodopa.
CONCLUSION: Initiation of levodopa therapy in patients with early and stable Parkinson's disease is associated with deterioration in visual memory functions, with relative preservation of the verbal memory.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16679640     DOI: 10.4103/0028-3886.24699

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  4 in total

1.  Drug safety monitoring in patients of movement disorders of a tertiary care hospital.

Authors:  Ananya Mandal; Suparna Chatterjee; Shyamal Kumar Das; Amar Mishra
Journal:  Indian J Pharmacol       Date:  2010-08       Impact factor: 1.200

Review 2.  Research in Parkinson's disease in India: A review.

Authors:  Pratibha Surathi; Ketan Jhunjhunwala; Ravi Yadav; Pramod Kumar Pal
Journal:  Ann Indian Acad Neurol       Date:  2016 Jan-Mar       Impact factor: 1.383

3.  The Modality Effect on Delayed Free Recall in Non-demented Patients With Mild Parkinson's Disease Progression.

Authors:  Constantinos Kormas; Ioannis Zalonis; Ioannis Evdokimidis; Elisabeth Kapaki; Constantin Potagas
Journal:  Front Aging Neurosci       Date:  2019-07-23       Impact factor: 5.750

Review 4.  Approach to Cognitive Impairment in Parkinson's Disease.

Authors:  Qiang Zhang; Georgina M Aldridge; Nandakumar S Narayanan; Steven W Anderson; Ergun Y Uc
Journal:  Neurotherapeutics       Date:  2020-11-17       Impact factor: 6.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.